TITLE

CLINIC ROUNDUP

PUB. DATE
December 2007
SOURCE
BioWorld Today;12/4/2007, Vol. 18 Issue 234, p7
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section provides news briefs on the biotechnology industry as of December 4, 2007. Avicena Group Inc. of California reported positive Phase II data from its combination trial involving AL-08, a second-generation drug candidate for amyotrophic lateral sclerosis. Can-Fite BioPharma Ltd. of Israel submitted an investigational new drug application to start Phase I testing of CF102 for liver diseases. Ferring Pharmaceuticals of Switzerland completed the pivotal Phase III study for degarelix, its novel prostate cancer treatment.
ACCESSION #
27730184

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics